About
DenovAI Biotech develops AI-driven platforms for de novo protein design to create high-affinity therapeutic antibodies, small protein and peptide biologics, and diagnostic reporters.
Explore DenovAI Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.